SecSonar.com

Stevanato Group S.p.A. (STVN)

Stevanato Group S.p.A. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Stevanato Group S.p.A. (STVN) is a Medical - Instruments & Supplies company based in IT with a market capitalization of $5.2B. Revenue grew 3.2% year-over-year and the company generated $24.5M in free cash flow. This page tracks STVN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IT · 5.52K employees · IPO Jul 16, 2021

Valuation

Valuation & price

$17.99 · as of May 17, 2026 · -35.6% vs 52w high

36.6

P/E ratio

Latest-FY diluted EPS

3.48

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$27.61$20.52$13.43Jul 25Dec 25Jul 26Jul 7, 25$24.35Jul 9, 25$25.26Jul 11, 25$25.21Jul 15, 25$25.60Jul 17, 25$25.49Jul 21, 25$24.17Jul 23, 25$25.41Jul 25, 25$26.51Jul 29, 25$25.27Jul 31, 25$24.71Aug 4, 25$25.58Aug 6, 25$24.05Aug 11, 25$21.85Aug 13, 25$22.36Aug 15, 25$22.62Aug 19, 25$22.45Aug 21, 25$22.85Aug 25, 25$21.99Aug 27, 25$22.40Aug 29, 25$23.01Sep 3, 25$23.30Sep 5, 25$24.15Sep 9, 25$26.55Sep 11, 25$26.87Sep 16, 25$27.23Sep 18, 25$27.25Sep 22, 25$26.93Sep 24, 25$26.97Sep 26, 25$25.66Sep 30, 25$25.75Oct 2, 25$26.40Oct 6, 25$24.53Oct 8, 25$24.58Oct 10, 25$23.85Oct 14, 25$24.12Oct 16, 25$24.10Oct 21, 25$26.33Oct 23, 25$27.61Oct 27, 25$25.98Oct 29, 25$25.80Oct 31, 25$25.22Nov 4, 25$24.74Nov 6, 25$24.41Nov 10, 25$24.25Nov 12, 25$23.68Nov 14, 25$22.08Nov 18, 25$20.84Nov 20, 25$21.16Nov 25, 25$23.38Nov 28, 25$23.36Dec 2, 25$22.10Dec 4, 25$22.92Dec 8, 25$21.48Dec 10, 25$20.85Dec 12, 25$20.82Dec 16, 25$20.89Dec 18, 25$20.52Dec 22, 25$20.53Dec 24, 25$20.95Dec 29, 25$20.65Jan 2, 26$20.58Jan 6, 26$21.59Jan 8, 26$21.92Jan 12, 26$20.73Jan 14, 26$20.46Jan 16, 26$19.75Jan 21, 26$19.44Jan 23, 26$17.27Jan 27, 26$16.97Jan 29, 26$16.00Feb 2, 26$15.73Feb 4, 26$15.09Feb 9, 26$16.10Feb 11, 26$15.60Feb 13, 26$16.01Feb 18, 26$16.23Feb 20, 26$16.05Feb 24, 26$15.42Feb 26, 26$15.31Mar 2, 26$15.09Mar 4, 26$17.50Mar 6, 26$15.41Mar 10, 26$15.07Mar 12, 26$14.64Mar 17, 26$15.40Mar 19, 26$15.17Mar 23, 26$14.80Mar 25, 26$14.18Mar 27, 26$13.43Mar 31, 26$13.75Apr 2, 26$13.73Apr 7, 26$13.64Apr 9, 26$13.75Apr 13, 26$13.81Apr 15, 26$14.74Apr 17, 26$15.53Apr 22, 26$15.56Apr 24, 26$16.18Apr 28, 26$16.21Apr 30, 26$17.00May 4, 26$17.79May 6, 26$19.00May 8, 26$18.23May 12, 26$18.24May 14, 26$17.99May 18, 26$17.79May 20, 26$17.75May 22, 26$18.01May 28, 26$18.66Jun 1, 26$18.87Jun 3, 26$18.53Jun 5, 26$18.46Jun 9, 26$18.10Jun 11, 26$17.29Jun 15, 26$16.63Jun 17, 26$17.06Jun 22, 26$16.94Jun 24, 26$17.24Jun 26, 26$17.84Jul 2, 26$19.00
$13.4352-week range$27.95
Loading valuation history…

Fundamentals

Key fundamentals

$5.2B

Market cap

3.2%

Revenue growth (YoY)

29.0%

Gross margin

$24.5M

Free cash flow (USD)

$338M

Net debt

0.1%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$536.5MFY 2020$662.0MFY 2021$843.9MFY 2022$983.7MFY 2023$1.1BFY 2024$1.1BFY 2025$1.1B
$536.5M$1.1B

Free cash flow by year

2019 → 2025

FY 2019$-31.3MFY 2020$59.7MFY 2021$20.2MFY 2022$-139.8MFY 2023$-336.7MFY 2024$-157.8MFY 2025$21.4M
-$31.3M$21.4M

Gross margin by year

2021 → 2025

FY 202131.4%FY 202232.5%FY 202331.3%FY 202427.4%FY 202529.0%
31.4%29.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

4

Insider sells · 90 days

Earnings

Last report: 6-K filed Jun 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $26KMOREL DONALD E JR · Director · $25.5KJun 26, 2026Filing
  • Insider sellInsider Sell $26KBalachandran Madhavan · Director · $25.5KJun 26, 2026Filing
  • Insider sellInsider Sell $26KFEDERICI WILLIAM J · Director · $25.5KJun 26, 2026Filing
  • Insider sellInsider Sell $26KFlynn Karen · Director · $25.5KJun 26, 2026Filing
  • Annual reportAnnual Report FiledJun 5, 2026Filing
  • Quarterly reportQuarterly Report FiledMay 15, 2026Filing
  • Annual reportAnnual Report FiledMay 11, 2026Filing
  • Quarterly reportQuarterly Report FiledMay 7, 2026Filing
  • Quarterly reportQuarterly Report FiledMay 7, 2026Filing
  • Quarterly reportQuarterly Report FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is Stevanato Group S.p.A.'s market cap?

Stevanato Group S.p.A. (STVN) has a market capitalization of $5.2B.

What is STVN's P/E ratio?

STVN trades at a price-to-earnings ratio of 36.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is STVN's price-to-book (P/B) ratio?

STVN trades at 3.48 times book value per share.

Are insiders buying STVN stock?

SEC Form 4 filings show no open-market insider buys at Stevanato Group S.p.A. in the last 90 days (4 sells).

Same arena

Related companies in Medical - Instruments & Supplies

TFX

Teleflex Incorporated

$5.7B

AVTR

Avantor, Inc.

$6.4B

MMSI

Merit Medical Systems, Inc.

$3.8B

ICUI

ICU Medical, Inc.

$3.4B

RGEN

Repligen Corporation

$7.1B

HAE

Haemonetics Corporation

$3.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.